General Range
FORT HCQS 200
Price on request/100 · MOQ 100 boxes
FORT HCQS 200 Tablets by Fortune Labs contain Hydroxychloroquine Sulphate 200 mg, a prescription antimalarial and disease-modifying antirheumatic medicine used for selected autoimmune and malaria-related conditions. Hydroxychloroquine helps regulate immune responses and reduce inflammation, making it an established treatment option for rheumatoid arthritis and certain forms of lupus. It may also be prescribed for malaria caused by susceptible parasites when supported by current treatment guidelines. Available in blister strip packaging of 10 × 15 tablets, FORT HCQS 200 provides an oral treatment option for eligible patients. The medicine requires medical supervision, considering retinal health, kidney function, cardiovascular risks, potential drug interactions and appropriate treatment duration. Long-term treatment may require regular eye examinations.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Hydroxychloroquine Sulphate Tablets I.P.
- Packaging Type
- Tablet Blister Strips with Printed Carton Box
- Packaging Size
- 10 × 15
- Dosage Form
- Tablet
- Treatment
- Helps manage joint inflammation, swelling and stiffness associated with rheumatoid arthritis.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
